GlassScriptPhysician profile
Robert Leslie Bloom
NPI 1821014846
$4,106.49
in general payments reported to CMS, 2019-2025
38 companies · $22.43 in 2025
The $22.43 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,426 · 2020: $322 · 2021: $122 · 2022: $1,610 · 2023: $604 · 2025: $22.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $626.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $626.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $522.25 | 2019-2023 | Nucala, Trelegy Ellipta |
| Genentech USA, INC. | $499.36 | 2019-2023 | Xolair, Tecentriq |
| Genzyme Corporation | $416.73 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $409.71 | 2019-2023 | Ofev |
| Astrazeneca Pharmaceuticals LP | $352.04 | 2019-2023 | Breztri, Fasenra, Tezspire |
| Regeneron Healthcare Solutions, INC. | $174.98 | 2019-2022 | |
| Insmed, INC. | $164.90 | 2019-2023 | Arikayce |
| Janssen Pharmaceuticals, INC | $154.14 | 2019-2022 | |
| Mylan Specialty L.P. | $152.45 | 2019-2023 | Yupelri |
| Mallinckrodt Hospital Products INC. | $94.24 | 2022-2023 | Acthar |
| Grifols USA, LLC | $88.20 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $82.16 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $80.57 | 2019-2022 | |
| Philips North America LLC | $76.93 | 2019-2022 | |
| United Therapeutics Corporation | $75.51 | 2019-2022 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $68.12 | 2022 | |
| Amgen INC. | $62.36 | 2021-2023 | Tezspire |
| E.R. Squibb & Sons, L.L.C. | $59.42 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $59.27 | 2019-2022 | |
| Gilead Sciences, INC. | $58.44 | 2019 | |
| Pfizer INC. | $45.43 | 2022 | |
| Merck Sharp & Dohme LLC | $41.98 | 2019-2020 | |
| Vapotherm INC | $40.55 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $38.92 | 2019 | |
| Seagen INC. | $31.74 | 2019 | |
| Alcresta Therapeutics, INC. | $28.91 | 2022 | |
| Electromed, INC. | $27.62 | 2019-2023 | Smartvest |
| Sunovion Pharmaceuticals INC. | $23.73 | 2019 | |
| Optinose US, INC. | $22.85 | 2022 | |
| Janssen Biotech, INC. | $22.43 | 2025 | Rybrevant |
| Sanofi Pasteur INC. | $20.17 | 2020 | |
| Phadia US INC. | $18.81 | 2022 | |
| Harmony Biosciences LLC | $18.09 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $17.67 | 2019 | |
| Csl Behring | $16.82 | 2019 | |
| Circassia INC. | $14.56 | 2019 | |
| Idorsia Pharmaceuticals US INC | $13.02 | 2023 | Quviviq |
| Astellas Pharma US INC | $11.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Bloom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.